esubmission - Are you really Compliant?

Similar documents
PharmaSUG Paper AD03

Submission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA

Lex Jansen Octagon Research Solutions, Inc.

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library

Automate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc.

Implementing CDISC Using SAS. Full book available for purchase here.

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0

Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission

Introduction to ADaM and What s new in ADaM

An Alternate Way to Create the Standard SDTM Domains

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development

SAS Clinical Data Integration 2.6

Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS

Applying ADaM Principles in Developing a Response Analysis Dataset

SDTM Attribute Checking Tool Ellen Xiao, Merck & Co., Inc., Rahway, NJ

Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC

Automation of SDTM Programming in Oncology Disease Response Domain Yiwen Wang, Yu Cheng, Ju Chen Eli Lilly and Company, China

SAS Clinical Data Integration 2.4

Lex Jansen Octagon Research Solutions, Inc.

Optimization of the traceability when applying an ADaM Parallel Conversion Method

PhUSE US Connect 2019

Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit

Why organizations need MDR system to manage clinical metadata?

Updates on CDISC Standards Validation

How to handle different versions of SDTM & DEFINE generation in a Single Study?

PMDA Valida+on Rules. Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency. Max Kanevsky December 10, 2015

ABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India

Streamline SDTM Development and QC

PharmaSUG Paper PO22

Customer oriented CDISC implementation

Revision of Technical Conformance Guide on Electronic Study Data Submissions

SAS offers technology to facilitate working with CDISC standards : the metadata perspective.

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA

Step Up Your ADaM Compliance Game Ramesh Ayyappath & Graham Oakley

Dealing with changing versions of SDTM and Controlled Terminology (CT)

Experience of electronic data submission via Gateway to PMDA

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA

Study Data Reviewer s Guide Completion Guideline

Material covered in the Dec 2014 FDA Binding Guidances

CDISC SDTM and ADaM Real World Issues

Creating Define-XML v2 with the SAS Clinical Standards Toolkit

Comparison of FDA and PMDA Requirements for Electronic Submission of Study Data

Dataset-XML - A New CDISC Standard

An Efficient Solution to Efficacy ADaM Design and Implementation

SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components

Out-of-the-box %definexml

PharmaSUG Paper DS24

Common Programming Errors in CDISC Data

Best Practice for Explaining Validation Results in the Study Data Reviewer s Guide

From SDTM to displays, through ADaM & Analyses Results Metadata, a flight on board METADATA Airlines

Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database

How to write ADaM specifications like a ninja.

Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples

Pharmaceuticals, Health Care, and Life Sciences. An Approach to CDISC SDTM Implementation for Clinical Trials Data

ADaM Compliance Starts with ADaM Specifications

Traceability Look for the source of your analysis results

CDISC Variable Mapping and Control Terminology Implementation Made Easy

What is high quality study metadata?

PhUSE Paper SD09. "Overnight" Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland

DIA 11234: CDER Data Standards Common Issues Document webinar questions

NCI/CDISC or User Specified CT

Introduction to Define.xml

SAS Clinical Data Integration Server 2.1

Generating Define.xml from Pinnacle 21 Community

PharmaSUG Paper PO10

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008

Optimization of the traceability when applying an ADaM Parallel Conversion Method

%check_codelist: A SAS macro to check SDTM domains against controlled terminology

PharmaSUG Paper PO21

Legacy to SDTM Conversion Workshop: Tools and Techniques

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA

When ANY Function Will Just NOT Do

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

Study Data Reviewer s Guide

TS04. Running OpenCDISC from SAS. Mark Crangle

Codelists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California

SDTM-ETL 3.2 User Manual and Tutorial

Study Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata

Data Integrity through DEFINE.PDF and DEFINE.XML

A SDTM Legacy Data Conversion

Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA

Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets

Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area

Clinical Metadata Metadata management with a CDISC mindset

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets

A Taste of SDTM in Real Time

Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA

Automated Creation of Submission-Ready Artifacts Silas McKee, Accenture, Pennsylvania, USA Lourdes Devenney, Accenture, Pennsylvania, USA

Considerations on creation of SDTM datasets for extended studies

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

Managing Custom Data Standards in SAS Clinical Data Integration

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards

Paper DS07 PhUSE 2017 CDISC Transport Standards - A Glance. Giri Balasubramanian, PRA Health Sciences Edwin Ponraj Thangarajan, PRA Health Sciences

define.xml: A Crash Course Frank DiIorio

Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences

SDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6

STUDY DATA TECHNICAL CONFORMANCE GUIDE

Pharmaceutical Applications

Transcription:

ABSTRACT PharmaSUG 2018 - Paper SS21 esubmission - Are you really Compliant? Majdoub Haloui, Merck & Co., Inc., Upper Gwynedd, PA, USA Suhas R. Sanjee, Merck & Co., Inc., Upper Gwynedd, PA, USA Pinnacle 21 Enterprise is a valuable tool for SDTM, ADaM and define.xml validation. However, the tool is still evolving and has some limitations, so additional quality checks need to be created to supplement the tool s assessments to ensure accuracy, validity and completeness of SDTM/ADaM datasets as well as the define.xml. Adding manual quality checks can be cumbersome and time consuming. In this paper, we will discuss the extra quality checks that are implemented beyond what is available in the Pinnacle 21 Enterprise tool. The paper focuses on how these checks are created and an efficient approach for converting define.xml into SAS datasets so they can be validated against the actual SDTM/ADaM datasets. INTRODUCTION Pinnacle 21 Enterprise is the leading industry web-based application used by sponsors and CROs to validate SDTM / ADaM datasets and define.xml against CDISC standards. The FDA and PMDA are also using Pinnacle 21 Enterprise to review submission data from sponsors. Pinnacle 21 Enterprise has many useful features, including validating SDTM, ADaM and define.xml as well as generating define.xml version 2.0. This paper introduces new SAS-based quality checks that supplement what is already available in the Pinnacle 21 Enterprise tool. QUALITY CHECK DESCRIPTIONS Having SDTM/ADaM dataset attributes consistent with the define.xml can contribute to an efficient and seamless regulatory review process, potentially expediting drug approval. The following table provides a list of checks developed by Merck & Co., Inc. to address checks that are not performed by Pinnacle 21 Enterprise but are needed to meet the requirements defined by the current regulatory agency standards and expectations. Consistency checks between the define.xml documents and the submission data are among the supplemental checks needed to produce quality deliverables. SAS Macro check0csr0xpt Checks Implemented All submission XPT datasets must match the final sas7bdat datasets that were used to develop CSR TFLs. check0define/ check0def0data0consistency The define.xml must contain controlled terminology for all variables that use controlled terminology, and must be consistent with the SDTM-IG/ADaM IG version being used for the study. Check consistency between data and define.xml (define). o All datasets in submission must be defined in define.xml and vice versa o Dataset label must match between define and data o All variables in XPT files must be defined in define.xml and vice versa o Variable labels must match between define and data o Variable order must match between define and data o Variable type must match between define and data o All controlled terminology values in data must be present in the define 1

SAS Macro check0file0names check0keys0dups check0meta check0meta0adam0sdtm check0orphans check0ts Checks Implemented The ISO 8601 format must not be provided as a Codelist or an External codelist Datasets must be listed in alphabetical order by name attribute within each class in the define.xml file. SDTM o Trial Design Datasets o Special-purpose Domains o Interventions Domains o Events Domains o Findings Domains o Findings About o Relationship Datasets ADaM o Subject Level Analysis Dataset o Basic Data Structure o ADaM Other File names must only contain letters, numbers or hyphens and must be in lower case. No underscores or blanks are allowed All Keys listed in the define,when used, must represent uniqueness in the data Dataset labels and variable names /labels must not contain: punctuation, dashes, spaces, or other non-alphanumeric symbols (like line breaks and carriage returns) Across all ADaM datasets, core variables (i.e., AGEGRP, TRT01P, population flags, etc.) must have consistent metadata (i.e., label, type, etc) Dataset labels must be unique across SDTM & ADaM datasets. (ADaM dataset labels are required to be different from SDTM labels) Variables inherited from SDTM must retain the same attributes except length For ADaM datasets, only SAS built-in Date or Datetime formats may be used. Check if the format is consistent across the same submission: date7, datetime, etc Check for RELREC or SUPPQUAL domains that have references to non-existing records Study Start Date in the TS domain, the TSVAL must be populated where TSPARMCD = SSTDTC check0visit The Trial Visits (TV) and Subject Visits (SV) domains should be consistent with other domains VISIT, VISITNUM (if it exists) from all of the domains should be consistent with TV/SV Usage of VISITNUM values must be consistent across domains. All values of Visit Number (VISITNUM) must be the same for a given value of Visit Name (VISIT) check0xpt Variables must not contain customized format in XPT for SDTM STUDYID in all XPT files must be consistent and correct for the given study file0exist DM, define.xml, style sheet,trial Summary (TS) dataset and csdrg must be present in the tabulations\sdtm folder ADSL, define.xml, style sheet and adrg must be present in the analysis\adam folder Correct spelling of the file name (define.xml) is included in the submission check0arm All analysis variables and parameters referenced in the ARM must exist in the dataset All programs, macros, datasets and variables referenced in the define/arm must exist in the submission folder 2

MACRO DESIGN AND ARCHITECTURE The independent, interchangeable SAS macros described in the previous section perform the supplemental compliance/quality checks. This modular approach also provides users with flexibility to execute only applicable checks. This also provides improved quality, efficiency and ease of maintenance. Each macro/module outputs its own dataset containing the issues that it identifies. The suite of modules also creates or updates a Summary dataset to provide an overview of the issues. Figure 1 shows the block diagram of the macro design and architecture. SDTM Data & Define ADaM Data & Define Convert XML/XPT to SAS datasets as (%xml2sas) SAS Macros to implement compliance checks %check0def0data0consistency %check0keys0dups %check0meta0adam0sdtm %check0ts %check0visit %check0xpt %file0exist %check0csr0xpt %check0orphans %check0file0names SAS Datasets with summary & issues details Results in XML (%export2xml) Figure 1. Macro design and architecture Conversion from XML to SAS dataset(s) %xml2sas This macro converts the ADaM & SDTM define.xml to SAS datasets. It takes in the XML file, XML map as input and generates a SAS dataset that is used for compliance checks. Here is the sample code that extracts required information from the XML file (based on the XML map) and generates SAS datasets: filename define "c:\protxxx\metadata\define.xml"; filename SXLEMAP "c:\protxxx\metadata\define.map"; *Assign library reference to XML file using XMLV2 engine; libname define xmlv2 xmlmap=sxlemap access=readonly; *Create output datasets; proc copy in=define out=outlib; run; The map files were generated using SAS XML mapper. Figure 2 shows an XML map with Type and SDTM Core information. Figure 2. Snapshot of XML map 3

Output XML File The output XML file Summary tab provides issue descriptions and frequencies (Figure 3). An individual tab for each compliance check module provides a detailed list of issues that it detects (Figures 4a, 4b & 4c). Figure 3. Snapshot of Summary tab in Output XML file Figure 4a. Snapshot showing details about the issues in ADaM attributes Figure 4b. Snapshot showing details about the issue with TS Figure 4c. Snapshot showing details about the issue where VISIT/VISITNUM variables are not consistent with SV/TV 4

CONCLUSION High quality study data and accompanying metadata are extremely important for the regulatory review process. They add significant value to the submission by allowing reviewers to efficiently interpret and understand submitted data. The result is a time savings for the regulatory reviewer, which can potentially expedite the drug approval. The modular SAS-based quality checks presented in this paper can help expedite the quality review time. REFERENCES 1. FDA STUDY DATA TECHNICAL CONFORMANCE GUIDE October 2017 https://www.fda.gov/downloads/forindustry/datastandards/studydatastandards/ucm384744.pdf 2. Sergiy Sirichenko, Max Kanevsky What is high quality study metadata? PharmaSUG 2016 3. Lex Jansen Understanding the define.xml and converting it to a relational database PharmaSUG 2009 CONTACT INFORMATION Your comments and questions are valued and encouraged. Contact the author at: Majdoub Haloui Merck & Co., Inc. 351 North Sumneytown Pike North Wales PA 19454-2505 Phone: 267-305-2629 E-mail: majdoub.haloui@merck.com Suhas R. Sanjee Merck & Co., Inc. 351 North Sumneytown Pike North Wales PA 19454-2505 Phone: 267-305-0878 E-mail: suhas_sanjee@merck.com SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. indicates USA registration. Other brand and product names are trademarks of their respective companies. 5